Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,826,972 shares of the medical equipment provider's stock after purchasing an additional 319,694 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.79% of Intuitive Surgical worth $1,475,566,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management increased its position in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after buying an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. lifted its stake in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after buying an additional 525 shares during the last quarter. Finally, Truist Financial Corp lifted its stake in Intuitive Surgical by 3.0% in the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock valued at $129,494,000 after buying an additional 7,298 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ISRG shares. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Royal Bank of Canada reduced their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, Evercore ISI lowered their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $598.95.

Insiders Place Their Bets

In related news, VP Fredrik Widman sold 810 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. This represents a 63.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 2,401 shares of the stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at $205,093. The trade was a 87.18% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 0.3%

Shares of ISRG stock opened at $561.63 on Tuesday. The company has a market capitalization of $201.30 billion, a P/E ratio of 87.62, a P/E/G ratio of 5.85 and a beta of 1.70. The stock has a 50 day moving average of $506.50 and a two-hundred day moving average of $537.23. Intuitive Surgical, Inc. has a 12 month low of $395.60 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the company earned $1.50 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.